ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress PR Newswire Sep 13, 2024 9:19pm
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference PR Newswire Sep 11, 2024 8:05pm
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024 PR Newswire Aug 5, 2024 11:00am